Cargando…
Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies
Clinical trials and real-world data have shown that long-acting injectable antipsychotics (LAIs) might be an effective therapeutic option also for people with bipolar disorder (BD). However, complementing evidence from mirror-image studies investigating LAIs in BD is scattered and has not been syste...
Autores principales: | Bartoli, Francesco, Cavaleri, Daniele, Nasti, Christian, Palpella, Dario, Guzzi, Pierluca, Riboldi, Ilaria, Crocamo, Cristina, Pappa, Sofia, Carrà, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10041584/ https://www.ncbi.nlm.nih.gov/pubmed/36994116 http://dx.doi.org/10.1177/20451253231163682 |
Ejemplares similares
-
The place of long-acting injectable antipsychotics in the treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2023) -
Implementing gradual, hyperbolic tapering of long-acting injectable antipsychotics by prolonging the inter-dose interval: an in silico modelling study
por: O’Neill, James R., et al.
Publicado: (2023) -
Antipsychotics and structural brain changes: could treatment adherence explain the discrepant findings?
por: Emsley, Robin
Publicado: (2023) -
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia
por: Turkoz, Ibrahim, et al.
Publicado: (2023) -
Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia
por: Riboldi, Ilaria, et al.
Publicado: (2022)